Streptococcus pyogenes M protein (M protein)

Streptococcus pyogenes M protein is a major, surface-exposed virulence factor produced by Group A Streptococcus (GAS, Streptococcus pyogenes). It is anchored to the bacterial cell wall by a C-terminal LPXTG motif and is attached via the transpeptidase sortase A[1][4][6]. The molecule is an α-helical coiled-coil protein that extends from the cell surface, mediating multiple key functions: resisting phagocytosis by binding and inactivating host factor H (thus inhibiting complement opsonization); binding host extracellular matrix proteins such as fibronectin; and facilitating adhesion to host tissues, which promotes colonization and dissemination[1][2][4][5][8]. The M protein is encoded by the emm gene, which displays extensive sequence variability, allowing immune escape and complicating vaccine design[1][7]. Antibodies generated against the M protein can neutralize its anti-phagocytic function and mediate opsonophagocytosis. However, certain anti-M protein antibodies may cross-react with human tissues, such as heart muscle, contributing to autoimmune complications like rheumatic fever[6]. The M protein is the primary target for current vaccine strategies and is a key biomarker for epidemiological and diagnostic purposes in streptococcal infection[7][8]. No approved drugs directly target the M protein, but passive immunization and vaccine candidates are in active research and development.

Other names

Group A Streptococcus M proteinGAS M proteinStreptococcal M proteinemm gene product

Not applicable for classical drugs, but immune interventions (e.g., vaccines, antibodies) act by neutralizing the M protein’s function, preventing immune evasion and promoting opsonophagocytosis[6][8].